Chinese device maker Venus Medtech to raise up to $381m in HK IPO

Venus Medtech, a Chinese company that produces heart valve replacement devices, plans to raise up to $381 million in an initial public offering (IPO) in Hong Kong next month against headwinds including civil unrest in the Asian financial hub for nearly six months.